Join
Live feed
·
INSIDERFilingvia Quantisnow
ACADIA Pharmaceuticals Inc. logo

EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. sold $76,396 worth of shares (3,506 units at $21.79) as part of a pre-agreed trading plan and converted options into 6,815 shares, increasing direct ownership by 5% to 66,145 units (SEC Form 4) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACAD (ACADIA Pharmaceuticals Inc.) and more on Quantisnow.